ArticleInvestigational new drugs2021

A phase 1a/1b trial of CSF-1R inhibitor LY3022855 in combination with durvalumab or tremelimumab in patients with advanced solid tumors.

Gerald S Falchook et al.PubMed ↗Publisher ↗

No numbers read from the abstract.